Overactive Bladder Successfully Treated with Duloxetine in a Female Adolescent
0
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Overactive bladder (OAB) is defined as urgency, usually with frequency and nocturia, and with or without urge incontinence. Duloxetine, an antidepressant that inhibits reuptake of serotonin and norepinephrine, is indicated for the treatment of stress urinary incontinence in Europe. In this paper, we present a case of a 17-year-old female patient with OAB and depressive symptoms who was successfully treated with duloxetine. This case suggests duloxetine can be an option for patient with OAB, and it also highlights the need for further studies of duloxetine’s use in the treatment of OAB.
Abstract
Overactive bladder (OAB) is defined as urgency, usually with frequency and nocturia, and with or without urge incontinence. Duloxetine, an antidepressant that inhibits reuptake of serotonin and norepinephrine, is indicated for the treatment of stress urinary incontinence in Europe. In this paper, we present a case of a 17-year-old female patient with OAB and depressive symptoms who was successfully treated with duloxetine. This case suggests duloxetine can be an option for patient with OAB, and it also highlights the need for further studies of duloxetine’s use in the treatment of OAB.
참고문헌 (13)
- Wein AJ., "Re : An International Urogynecological Association(IUGA)", International Continence Society(ICS)joint report on the terminology for female pelvic floor dysfunction, 2011, pp.185, 1812~
- Eli Lilly and Company., "Highlights of prescribing information" (2012), Eli Lilly
- Guay DR., "Duloxetine for management of stress urinary incontinence", Am J Geriatr Pharmacother, 3, pp.25~38 (2005)
- Millard RJ., "Duloxetine vs placebo in the treatment of stress urinary incontinence : a four-continent randomized clinical trial", BJU Int, 93, pp.311~318 (2004)
- Di Rezze S., "Duloxetine for the treatment of overactive bladder syndrome in multiple sclerosis : a pilot study", Clin Neuropharmacol, 35, pp.231~234 (2012)
- Steers WD., "Duloxetine compared with placebo for treating women with symptoms of overactive bladder", BJU Int, 100, pp.337~345 (2007)
- Basu M., "Detrusor overactivity successfully treated with duloxetine", J Obstet Gynaecol, 27, pp.438~440 (2007)
- Jost W., "Duloxetine : mechanism of action at the lower urinary tract and Onuf's nucleus", Clin Auton Res, 14, pp.220~227 (2004)
- Verhamme KM., "Drug-induced urinary retention : incidence, management and prevention", Drug Saf, 31, pp.373~388 (2008)
- Thor KB., "Effects of duloxetine, a combined serotonin and norepinephrine reuptake inhibitor, on central neural control of lower urinary tract function in the chloralose-anesthetized female cat", J Pharmacol Exp Ther, 274, pp.1014~1024 (1995)
- Nitti V., "Clinical testing for overactive bladder", Can Urol Assoc J, 5(5 Suppl 2), pp.S137~S138 (2011)
- Milsom I., "Effect of bothersome overactive bladder symptoms on healthrelated quality of life, anxiety, depression, and treatment seeking in the United States : results from EpiLUTS", Urology, 80, pp.90~96 (2012)
- Nicolson P., "It's just the worry about not being able to control it A qualitative study of living with overactive bladder", Br J Health Psychol, 13, pp.343~359 (2008)